Concomitant use of warfarin and ticagrelor as an alternative to triple antithrombotic therapy after an acute coronary syndrome

Thrombosis Research - Tập 135 Số 1 - Trang 26-30 - 2015
Oscar Ö. Braun1, Besim Bico2, Uzma Chaudhry3, Henrik Wagner4, Sasha Koul5, Patrik Tydén6, Fredrik Scherstén7, Stefan Jovinge8, Henrik Renlund9, J. Gustav Smith10, Jesper van der Pals11
1Department of Cardiology, Skåne University Hospital, Lund University, Lund and Malmö, Sweden. Electronic address: [email protected].
2Department of Cardiology, Skåne University Hospital, Lund University, Lund and Malmö, Sweden. Electronic address: [email protected].
3Department of Internal Medicine, Helsingborg Hospital, Lund University, Lund and Helsingborg, Sweden. Electronic address: [email protected].
4Department of Internal Medicine, Helsingborg Hospital, Lund University, Lund and Helsingborg, Sweden. Electronic address: [email protected].
5Department of Cardiology, Skåne University Hospital, Lund University, Lund and Malmö, Sweden. Electronic address: [email protected].
6Department of Cardiology, Skåne University Hospital, Lund University, Lund and Malmö, Sweden. Electronic address: [email protected].
7Department of Cardiology, Skåne University Hospital, Lund University, Lund and Malmö, Sweden. Electronic address: [email protected].
8Department of Cardiology, Skåne University Hospital, Lund University, Lund and Malmö, Sweden. Electronic address: [email protected].
9Department for Coagulation Disorders, Skåne University Hospital, Lund University, Lund and Malmö, Sweden. Electronic address: [email protected].
10Department of Cardiology, Skåne University Hospital, Lund University, Lund and Malmö, Sweden. Electronic address: [email protected].
11Department of Cardiology, Skåne University Hospital, Lund University, Lund and Malmö, Sweden. Electronic address: [email protected].

Tóm tắt

Từ khóa


Tài liệu tham khảo

Holmes, 2009, Combining antiplatelet and anticoagulant therapies, J Am Coll Cardiol, 54, 95, 10.1016/j.jacc.2009.03.044

Wysowski, 2007, Bleeding complications with warfarin use: a prevalent adverse effect resulting in regulatory action, Arch Intern Med, 167, 1414, 10.1001/archinte.167.13.1414

Becker, 2008, The primary and secondary prevention of coronary artery disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition), Chest, 133, 776S, 10.1378/chest.08-0685

Silber, 2005, Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology, Eur Heart J, 26, 804, 10.1093/eurheartj/ehi138

King, 2008, 2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines, J Am Coll Cardiol, 51, 172, 10.1016/j.jacc.2007.10.002

2002, Antithrombotic Trialists' Collaboration, Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction and stroke in high risk patients, Br Med J, 71

Quinlan, 2011, Implications of variability in definition and reporting of major bleeding in randomized trials of oral P2Y12 inhibitors for acute coronary syndromes, Eur Heart J, 32, 2256, 10.1093/eurheartj/ehr143

Mehta, 2000, The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme; rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease, Eur Heart J, 21, 2033, 10.1053/euhj.2000.2474

Smith, 2012, Triple antithrombotic therapy following an acute coronary syndrome: prevalence, outcomes and prognostic utility of the HAS-BLED score, EuroIntervention, 8, 672, 10.4244/EIJV8I6A105

Ruiz-Nodar, 2008, Anticoagulant and antiplatelet therapy use in 426 patients with atrial fibrillation undergoing percutaneous coronary intervention and stent implantation implications for bleeding risk and prognosis, J Am Coll Cardiol, 51, 818, 10.1016/j.jacc.2007.11.035

Karjalainen, 2007, Safety and efficacy of combined antiplatelet-warfarin therapy after coronary stenting, Eur Heart J, 28, 726, 10.1093/eurheartj/ehl488

Dewilde, 2009, Design and rationale of the WOEST trial: What is the Optimal antiplatElet and anticoagulant therapy in patients with oral anticoagulation and coronary StenTing (WOEST), Am Heart J, 158, 713, 10.1016/j.ahj.2009.09.001

Dewilde, 2013, Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial, Lancet, 381, 1107, 10.1016/S0140-6736(12)62177-1

Snoep, 2007, Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: a systematic review and meta-analysis, Am Heart J, 154, 221, 10.1016/j.ahj.2007.04.014

Gurbel, 2010, Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND study, Circulation, 121, 1188, 10.1161/CIRCULATIONAHA.109.919456

Stenestrand, 2001, Early statin treatment following acute myocardial infarction and 1-year survival, JAMA, 285, 430, 10.1001/jama.285.4.430

Pisters, 2010, A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey, Chest, 138, 1093, 10.1378/chest.10-0134

Mehran, 2011, Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium, Circulation, 123, 2736, 10.1161/CIRCULATIONAHA.110.009449

Lip, 2010, Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation, Chest, 137, 263, 10.1378/chest.09-1584

Yusuf, 2001, Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation, N Engl J Med, 345, 494, 10.1056/NEJMoa010746

Wallentin, 2009, Ticagrelor versus clopidogrel in patients with acute coronary syndromes, N Engl J Med, 361, 1045, 10.1056/NEJMoa0904327

Wiviott, 2007, Prasugrel versus clopidogrel in patients with acute coronary syndromes, N Engl J Med, 357, 2001, 10.1056/NEJMoa0706482

Biondi-Zoccai, 2011, Adjusted indirect comparison meta-analysis of prasugrel versus ticagrelor for patients with acute coronary syndromes, Int J Cardiol, 150, 325, 10.1016/j.ijcard.2010.08.035

Sorensen, 2009, Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data, Lancet, 374, 1967, 10.1016/S0140-6736(09)61751-7

Paikin, 2010, Triple antithrombotic therapy in patients with atrial fibrillation and coronary artery stents, Circulation, 121, 2067, 10.1161/CIRCULATIONAHA.109.924944

Sarafoff, 2013, Triple therapy with aspirin, prasugrel, and vitamin K antagonists in patients with drug-eluting stent implantation and an indication for oral anticoagulation, J Am Coll Cardiol, 61, 2060, 10.1016/j.jacc.2013.02.036

Lamberts, 2014, Antiplatelet Therapy for Stable Coronary Artery Disease in Atrial Fibrillation Patients on Oral Anticoagulant: A Nationwide Cohort Study, Circulation, 129, 1577, 10.1161/CIRCULATIONAHA.113.004834

Granger, 2011, Apixaban versus warfarin in patients with atrial fibrillation, N Engl J Med, 365, 981, 10.1056/NEJMoa1107039

Connolly, 2009, Dabigatran versus warfarin in patients with atrial fibrillation, N Engl J Med, 361, 1139, 10.1056/NEJMoa0905561

Patel, 2011, Rivaroxaban versus warfarin in nonvalvular atrial fibrillation, N Engl J Med, 365, 883, 10.1056/NEJMoa1009638

Wieloch, 2011, Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculA, Eur Heart J, 32, 2282, 10.1093/eurheartj/ehr134

Thông tin
Thông tin xuất bản

Thrombosis Research

Tập 135 Số 1

26-30

Thông tin tác giả